SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009731
Filing Date
2015-11-05
Accepted
2015-11-05 17:07:30
Documents
15
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctic-10q_20150930.htm 10-Q 1550700
2 EX-10.1 ctic-ex101_14.htm EX-10.1 15020
3 EX-10.2 ctic-ex102_16.htm EX-10.2 85077
4 EX-10.3 ctic-ex103_17.htm EX-10.3 124984
5 EX-10.4 ctic-ex104_18.htm EX-10.4 160248
6 EX-10.5 ctic-ex105_19.htm EX-10.5 90016
7 EX-31.1 ctic-ex311_9.htm EX-31.1 11427
8 EX-31.2 ctic-ex312_11.htm EX-31.2 12410
9 EX-32 ctic-ex32_10.htm EX-32 12979
  Complete submission text file 0001564590-15-009731.txt   4554140

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT ctic-20150930.xml EX-101.INS 539749
11 XBRL TAXONOMY EXTENSION SCHEMA ctic-20150930.xsd EX-101.SCH 30220
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20150930_cal.xml EX-101.CAL 46017
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20150930_def.xml EX-101.DEF 104679
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20150930_lab.xml EX-101.LAB 270116
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20150930_pre.xml EX-101.PRE 191154
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 151201571
SIC: 2834 Pharmaceutical Preparations